Modifying Risk Factors in the Management of Erectile Dysfunction: A Review

Overview

Journal World J Mens Health

Date 2016 Aug 31

PMID 27574592

Citations 29

Authors

Kenneth J DeLay

Nora Haney

Wayne Jg Hellstrom

Affiliations

Soon will be listed here.

Abstract

Erectile dysfunction (ED) is prevalent among men and its presence is often an indicator of systemic disease. Risk factors for ED include cardiovascular disease, hypertension, diabetes mellitus (DM), tobacco use, hyperlipidemia, hypogonadism, lower urinary tract symptoms, metabolic syndrome, and depression. Addressing the modifiable risk factors frequently improves a patient's overall health and increases lifespan. The literature suggests that smoking cessation, treatment of hyperlipidemia, and increasing physical activity will improve erectile function in many patients. How the treatment of DM, depression, and hypogonadism impacts erectile function is less clear. Clinicians need to be aware that certain antihypertensive agents can adversely impact erectile function. The treatment of men with ED needs to address the underlying risk factors to ameliorate the disease process.

Citing Articles

Targeting TRPC-5 Channel Inhibition to Improve Penile Vascular Function in Erectile Dysfunction.

El Assar M, Garcia-Gomez B, La Fuente J, Alonso-Isa M, Martinez-Salamanca J, Fernandez A Int J Mol Sci. 2025; 26(4).

PMID: 40003900 PMC: 11855833. DOI: 10.3390/ijms26041431.

A Mendelian randomization study on associations between plasma lipidome, circulating inflammatory proteins, and erectile dysfunction.

Yu J, Liang P Transl Androl Urol. 2025; 13(12):2724-2734.

PMID: 39816232 PMC: 11732301. DOI: 10.21037/tau-24-378.

2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part II.

Chao T, Lin T, Cheng C, Wu Y, Ueng K, Wu Y Acta Cardiol Sin. 2024; 40(6):669-715.

PMID: 39582845 PMC: 11579689. DOI: 10.6515/ACS.202411_40(6).20240724B.

A Web-Based Survey of Patients Dispensed Viagra Connect Behind the Counter in UK: An Evaluation of Effectiveness of Additional Risk Minimization Measures.

Li J, Lem J, Younus M, Donde S, Collins J, Zou K Patient Prefer Adherence. 2024; 18:1345-1358.

PMID: 38957611 PMC: 11217141. DOI: 10.2147/PPA.S440339.

Association between dietary phytochemical index and risk of benign prostatic hyperplasia: a case-control study.

Mousavi S, Nouri M, Rad E, Kazemi R, Birjandi M, Coe S J Health Popul Nutr. 2024; 43(1):35.

PMID: 38429831 PMC: 10905850. DOI: 10.1186/s41043-024-00531-5.

References

Ghalayini I, Al-Ghazo M, Al-Azab R, Bani-Hani I, Matani Y, Barham A . Erectile dysfunction in a Mediterranean country: results of an epidemiological survey of a representative sample of men. Int J Impot Res. 2010; 22(3):196-203. DOI: 10.1038/ijir.2009.65. View

Austoni E, Mirone V, Parazzini F, Basile Fasolo C, Turchi P, Pescatori E . Smoking as a risk factor for erectile dysfunction: data from the Andrology Prevention Weeks 2001-2002 a study of the Italian Society of Andrology (s.I.a.). Eur Urol. 2005; 48(5):810-7. DOI: 10.1016/j.eururo.2005.03.005. View

Labairu-Huerta L, Padilla-Fernandez B, Arrondo-Arrondo J, Valverde-Martinez L, Martin-Rodriguez A, Silva-Abuin J . PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction. Arch Ital Urol Androl. 2015; 87(3):204-9. DOI: 10.4081/aiua.2015.3.204. View

Corona G, Isidori A, Buvat J, Aversa A, Rastrelli G, Hackett G . Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014; 11(6):1577-92. DOI: 10.1111/jsm.12536. View

Huang Y, Chin C, Chen C, Shindel A, Ho D, Lin C . Chronic Cigarette Smoking Impairs Erectile Function through Increased Oxidative Stress and Apoptosis, Decreased nNOS, Endothelial and Smooth Muscle Contents in a Rat Model. PLoS One. 2015; 10(10):e0140728. PMC: 4619638. DOI: 10.1371/journal.pone.0140728. View

Bivalacqua T, Rajasekaran M, Champion H, Wang R, Sikka S, Kadowitz P . The influence of castration on pharmacologically induced penile erection in the cat. J Androl. 1998; 19(5):551-7. View

Jeong S, Ham B, Park M, Oh M, Yoon D, Kim J . Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome. Korean J Urol. 2011; 52(8):566-71. PMC: 3162224. DOI: 10.4111/kju.2011.52.8.566. View

Kalka D, Domagala Z, Rakowska A, Womperski K, Franke R, Sylwina-Krauz E . Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic heart disease. Int J Impot Res. 2015; 28(1):14-9. DOI: 10.1038/ijir.2015.26. View

Okada K, Yamaguchi K, Chiba K, Miyake H, Fujisawa M . Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. Aging Male. 2014; 17(2):72-5. DOI: 10.3109/13685538.2014.888052. View

10.

Csoka A, Csoka A, Bahrick A, Mehtonen O . Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J Sex Med. 2008; 5(1):227-33. DOI: 10.1111/j.1743-6109.2007.00630.x. View

11.

Gupta B, Murad M, Clifton M, Prokop L, Nehra A, Kopecky S . The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011; 171(20):1797-803. DOI: 10.1001/archinternmed.2011.440. View

12.

Amiaz R, Pope Jr H, Mahne T, Kelly J, Brennan B, Kanayama G . Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011; 37(4):243-54. DOI: 10.1080/0092623X.2011.582425. View

13.

Hyde Z, Flicker L, Hankey G, Almeida O, McCaul K, Chubb S . Prevalence and predictors of sexual problems in men aged 75-95 years: a population-based study. J Sex Med. 2011; 9(2):442-53. DOI: 10.1111/j.1743-6109.2011.02565.x. View

14.

Kostis J, Dobrzynski J . The effect of statins on erectile dysfunction: a meta-analysis of randomized trials. J Sex Med. 2014; 11(7):1626-35. DOI: 10.1111/jsm.12521. View

15.

Gianatti E, Dupuis P, Hoermann R, Zajac J, Grossmann M . Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2014; 99(10):3821-8. DOI: 10.1210/jc.2014-1872. View

16.

McVary K . Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006; 97 Suppl 2:23-8. DOI: 10.1111/j.1464-410X.2006.06102.x. View

17.

Xie Y, Garban H, Ng C, Rajfer J, Gonzalez-Cadavid N . Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat. J Urol. 1997; 157(3):1121-6. View

18.

Rosen R, Wing R, Schneider S, Gendrano 3rd N . Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am. 2005; 32(4):403-17, v. DOI: 10.1016/j.ucl.2005.08.004. View

19.

Karazindiyanoglu S, Cayan S . The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male. 2008; 11(3):146-9. DOI: 10.1080/13685530802290438. View

20.

Rastrelli G, Giovannini L, Calogero A, Gianfrilli D, Serra E, Pizzocaro A . Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry. J Endocrinol Invest. 2016; 39(6):695-708. DOI: 10.1007/s40618-016-0461-5. View